1 unknown. .
Follow ProteoSys AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma Prostate Cancer, Benign Prostatic Hyperplasia | Unknown | ProteoSys AG | 750 | 2005-09-01 | 2007-02-05 |
Prostatic Hyperplasia (1) · Prostatic Intraepithelial Neoplasia (1) · Prostatic Neoplasms (1)